Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PMS-GENTAMICIN-BETAMETHASONE DIN 02238819

Status: Cancelled Pre Market
Holder: PHARMASCIENCE INC
Molecule: BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)

Health Canada record

Active ingredient(s)BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG
Dosage formLiquid
RouteOtic; Ophthalmic
SchedulePRESCRIPTION
ClassHuman
ATCS03CA06 BETAMETHASONE AND ANTIINFECTIVES
Original market date
Current status date01-Mar-2018
SourceHealth Canada DPD

Establishment licence of the holder

Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE)

DINProductCompanyFormStrengthStatus
02060884BETNESOL RETENTION ENEMA 5MG/100MLPALADIN PHARMA INC.EnemaBETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 5 MGCancelled Post Market
02063190BETNESOL TABLETSSHIRE PHARMA CANADA ULCTablet (Effervescent)BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 0.5 MGCancelled Post Market
00176834CELESTONE REPETABS 1MGSCHERING-PLOUGH CANADA INCTablet (Extended-Release)BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MGCancelled Post Market
02238818DOM-GENTAMICIN-BETAMETHASONEDOMINION PHARMACALLiquidBETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MGCancelled Pre Market
00682217GARASONE OPHTHALMIC AND OTIC SOLUTIONMERCK CANADA INCSolutionBETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MGCancelled Post Market
00586706GARASONE OPHTHALMIC OINTMENTMERCK CANADA INCOintmentBETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
27131998-10-06New Drug Submission (NDS)
Request a quote for PMS-GENTAMICIN-BETAMETHASONE

How to read a Canadian DIN record